{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tazarotene+Cream%2C+0.05%25", "query": { "intervention": "Tazarotene Cream, 0.05%" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 5, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-02T10:13:39.211Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02886702", "title": "A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Tazarotene Cream 0.05%", "type": "DRUG" }, { "name": "TAZORAC® (tazarotene) Cream 0.05%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fougera Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 855, "start_date": "2016-09-19", "completion_date": "2017-08-02", "has_results": true, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-10-02T10:13:39.211Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Hot Springs, Arkansas • Anaheim, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "North Hollywood", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02886702" }, { "nct_id": "NCT06042647", "title": "Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriasis Vulgaris" ], "interventions": [ { "name": "0.01% Halobetasol", "type": "DRUG" }, { "name": "0.045% Tazarotene", "type": "DRUG" }, { "name": "0.05% Clobetasol Propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dermatology Consulting Services, PLLC", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2023-07-13", "completion_date": "2023-11-13", "has_results": false, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-10-02T10:13:39.211Z", "location_count": 1, "location_summary": "High Point, North Carolina", "locations": [ { "city": "High Point", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06042647" }, { "nct_id": "NCT02785159", "title": "Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "IDP-118 Lotion", "type": "DRUG" }, { "name": "Tazorac Cream", "type": "DRUG" }, { "name": "IDP-118 Vehicle Lotion", "type": "DRUG" }, { "name": "IDP-118 Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch Health Americas, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 152, "start_date": "2016-02", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2020-08-20", "last_synced_at": "2026-10-02T10:13:39.211Z", "location_count": 14, "location_summary": "Encino, California • Orange Park, Florida • Pinellas Park, Florida + 10 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Orange Park", "state": "Florida" }, { "city": "Pinellas Park", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02785159" }, { "nct_id": "NCT00667589", "title": "Sorafenib-induced Hand- Foot Skin Reaction Treatment", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hand-foot Skin Reaction", "Rash" ], "interventions": [ { "name": "urea 40% cream", "type": "DRUG" }, { "name": "fluocinonide 0.05% cream", "type": "DRUG" }, { "name": "tazarotene 0.1% cream", "type": "DRUG" }, { "name": "bland emollient cream (Udderly smooth® Udder Cream)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2008-06", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2013-06-05", "last_synced_at": "2026-10-02T10:13:39.211Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00667589" }, { "nct_id": "NCT02160665", "title": "Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Tazarotene Cream, 0.05%", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" }, { "name": "Reference: Tazorac Cream, 0.05%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "G & W Laboratories Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 866, "start_date": "2014-05", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-11-03", "last_synced_at": "2026-10-02T10:13:39.211Z", "location_count": 1, "location_summary": "Arlington Heights, Illinois", "locations": [ { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02160665" } ] }